secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001558370-25-009992
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio receives Nasdaq deficiency notice for bid price below $1.00, has 180 days to cure
--------------------------------------------------------------------------------

- Received Nasdaq notice on July 29, 2025 for failing Minimum Bid Price of $1.00 for 30 consecutive business days.
- Company has until January 26, 2026 to regain compliance by closing at $1.00+ for at least 10 consecutive business days.
- If not cured, iBio may be eligible for additional 180 days if it meets other standards and notifies Nasdaq of intent to cure via reverse split.
- No immediate effect on listing; stock continues trading on Nasdaq Capital Market under 'IBIO'.
- Company intends to monitor bid price and consider options including reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/0001558370-25-009992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000155837025009992/ibio-20250729x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-009992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer